1134-928X
1134-928X
S1134-928X2018000200083
España
España
España
España
España
Spain
00
00
2018
00
00
2018
29
2
83
91
[
2016
27
4
4
161-7
]
[
2009
55
9
9
22-9
]
[
2014
46
1
1
28-38
]
[
2014
II
II
]
[
National Pressure Ulcer Advisory Panel
European Pressure Ulcer Advisory Panel
Pan Pacific Pressure Injury Alliance
2014
]
[
National Pressure Ulcer Advisory Panel
]
[
2011
22
1
1
26-34
]
[
2013
24
2
2
82-9
]
[
2000
10
2
2
59-62
]
[
2016
]
[
1987
12
1
1
8-16
]
[
2013
50
7
7
974-1003
]
[
2013
24
2
2
90-4
]
[
2008
30
5
5
36-42
]
[
2002
15
3
3
121-4
]
[
1997
20
2
2
26-31
]
[
2007
20
208-218-220
]
[
1996
1
1
1
7-18
]
[
2003
13
4
4
144-8
]
[
2006
17
3
3
145-72
]
[
2011
22
2
2
77-90
]
[
2008
]
[
2011
16
8
8
382-9
]
[
2006
10
10
]
[
2015
]
[
2018
35
1-10
]
[
GNEAUPP
]
[
2017
44
2
2
110-7
]
[
2007
16
6
6
568-74
]
[
2009
18
1
1
17-21
]
[
2016
25
127-34
]
[
2017
26
241-5
]
[
2012
58
7
7
18-31
]
[
2003
4
3
3
284-90
]
[
2017
26
8^sTherapy Supplement
8^sTherapy Supplement
Therapy Supplement
S4-S12
]
[
2013
28
585-95
]
[
]
[
2016
3
91-9
]
[
2016
12
4
4
24-9
]
[
2016
25
15^sTissue Viability Supplement
15^sTissue Viability Supplement
Tissue Viability Supplement
S14-26
]
[
2017
26
246-53
]
[
2007
34
3
3
260-9
]
[
2015
61
7
7
26-30
]